Dr Imran Aziz

MBChB (Honours), MRCP (UK), MRCP (Gastroenterology), MD (Research)

Clinical Medicine, School of Medicine and Population Health

Senior Clinical Lecturer in Gastroenterology

Honorary Consultant Gastroenterologist

i.aziz@sheffield.ac.uk

+44 114 226 1179 (NHS Secretary)

The Medical School

Full contact details

Dr Imran Aziz
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX

Profile

For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk

I qualified in Medicine with Honours in 2004 and undertook training in general medicine and gastroenterology until 2016. During this period, I also completed a postgraduate degree at the University of Sheffield, followed by a two-year post-doctoral fellowship in functional gastrointestinal disorders at the Sahlgrenska Academy, University of Gothenburg, Sweden. In late 2018, I was appointed Senior Clinical Lecturer and Honorary Consultant Gastroenterologist in Sheffield.

I am a Personal Academic Tutor and an Associate Director of Student Affairs for the University of Sheffield MBChB curriculum. I have successfully supervised undergraduate BMedSci and postgraduate research students to thesis/viva completion, including publications of original articles in high-impact journals. In view of my international expertise, I am co-author on the British Society of Gastroenterology guidelines on the management of irritable bowel syndrome and functional dyspepsia. In 2021, I was awarded the United European Gastroenterology Rising Star Award, a prize recognizing promising young clinician scientists across Europe. I serve on the editorial board of Gastroenterology, a leading international journal in the field of GI diseases.

Research interests: My research interests are in functional gastrointestinal disorders (e.g. irritable bowel syndrome and functional dyspepsia) and gluten-related disorders.

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S , Winning RC et al (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut.
Simons J, Shajee U, Palsson O, Simren M, Sperber AD, Törnblom H, Whitehead W & Aziz I (2022) Disorders of gut‐brain interaction: highly prevalent and burdensome yet under‐taught within medical education. United European Gastroenterology Journal.
Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A & Aziz I (2022) Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome : a randomized trial of traditional dietary advice, the low FODMAP diet and the gluten-free diet. Clinical Gastroenterology and Hepatology. View this article in WRRO
Parker S, Palsson O, Sanders DS, Simren M, Sperber AD, Törnblom H, Urwin H, Whitehead W & Aziz I (2021) Functional gastrointestinal disorders and associated health impairment in individuals with celiac disease. Clinical Gastroenterology and Hepatology.
Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, Fang X, Fukudo S, Ghoshal UC, Kellow J , Khatun R et al (2021) GREATER OVERLAP OF ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS LEADS TO INCREASED DISEASE SEVERITY AND POORER QUALITY OF LIFE.. Clin Gastroenterol Hepatol.
Aziz I & Simrén M (2020) The overlap between irritable bowel syndrome and organic gastrointestinal diseases. The Lancet Gastroenterology & Hepatology.
Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, David Tai FW, Afify S & Aziz I (2020) Diagnostic yield of colonoscopy in patients with symptoms compatible with Rome IV functional bowel disorders. Clinical Gastroenterology and Hepatology.
Shiha MG, Ashgar Z, Fraser EM, Kurien M & Aziz I (2020) High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria. EClinicalMedicine. View this article in WRRO
Lam CY, Palsson OS, Whitehead WE, Sperber AD, Tornblom H, Simren M & Aziz I (2020) Rome IV functional gastrointestinal disorders and health impairment in subjects with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome. Clinical Gastroenterology and Hepatology. View this article in WRRO
Aziz I, Whitehead WE, Palsson OS, Törnblom H & Simrén M (2020) An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Review of Gastroenterology & Hepatology, 14(1), 39-46. View this article in WRRO
Rej A, Aziz I, Tornblom H, Sanders DS & Simrén M (2019) The role of diet in irritable bowel syndrome: implications for dietary advice. Journal of Internal Medicine, 286(5), 490-502.
Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M & Törnblom H (2019) Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults. Clinical Gastroenterology and Hepatology, 17(5), 878-886.
Aziz I (2018) The global phenomenon of self-reported wheat sensitivity. American Journal of Gastroenterology, 113(7), 945-948. View this article in WRRO
Aziz I, Törnblom H, Palsson OS, Whitehead WE & Simrén M (2018) How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. The American Journal of Gastroenterology, 113(7), 1017-1025.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE & Simrén M (2018) Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. The Lancet Gastroenterology & Hepatology, 3(4), 252-262.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE & Simrén M (2018) The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. The American Journal of Gastroenterology, 113(1), 86-96.
Aziz I, Peerally MF, Barnes JH, Kandasamy V, Whiteley JC, Partridge D, Vergani P, Cross SS, Green PH & Sanders DS (2017) The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut, 66, 1563-1572. View this article in WRRO
Aziz I, Törnblom H & Simrén M (2017) Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome. Current Opinion in Gastroenterology, 33(3), 196-202. View this article in WRRO
Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M & Sanders DS (2015) Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clinical Gastroenterology and Hepatology, 14(5), 696-703.e1.
Aziz I, Mumtaz S, Bholah H, Chowdhury FU, Sanders DS & Ford AC (2015) High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria. Clinical Gastroenterology and Hepatology, 13(9), 1650-1655.e2.
Aziz I, Hadjivassiliou M & Sanders DS (2015) The spectrum of noncoeliac gluten sensitivity. Nature Reviews Gastroenterology & Hepatology, 12(9), 516-526.
Aziz I, Branchi F, Pearson K, Priest J & Sanders DS (2015) A Study Evaluating the Bidirectional Relationship Between Inflammatory Bowel Disease and Self-reported Non-celiac Gluten Sensitivity. Inflammatory Bowel Diseases, 21(4), 847-853.
Aziz I, Lewis NR, Hadjivassiliou M, Winfield SN, Rugg N, Kelsall A, Newrick L & Sanders DS (2014) A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. European Journal of Gastroenterology & Hepatology, 26(1), 33-39.
Aziz I, Hadjivassiliou M & Sanders DS (2012) Does gluten sensitivity in the absence of coeliac disease exist?. BMJ, 345(nov30 1), e7907-e7907.
Evans KE, Aziz I, Cross SS, Sahota GRK, Hopper AD, Hadjivassiliou M & Sanders DS (2011) A Prospective Study of Duodenal Bulb Biopsy in Newly Diagnosed and Established Adult Celiac Disease. American Journal of Gastroenterology, 106(10), 1837-1742.
Aziz I, Evans KE, Hopper AD, Smillie DM & Sanders DS (2010) A prospective study into the aetiology of lymphocytic duodenosis. Alimentary Pharmacology & Therapeutics, 32(11-12), 1392-1397.
Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S & Aziz I () Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterology & Motility.
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP , Moss-Morris R et al () British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut.

Chapters

Aziz I & Simrén M (2020) Small Intestinal Bacterial Overgrowth, Encyclopedia of Gastroenterology (pp. 454-458). Elsevier
Aziz I & Simrén M (2020) Irritable Bowel Syndrome, Encyclopedia of Gastroenterology (pp. 312-323). Elsevier

All publications

Journal articles

Ball AJ, Ray M, Manji A, Aziz I, Sargur RB & Kurien M (2024) Faecal immunochemical testing in symptomatic primary care patients: a diagnostic accuracy study. European Journal of Cancer Care, 2024(1). View this article in WRRO
Raju SA, Bowker-Howell FJ, Aziz I, Thoufeeq M, Lobo AJ, Gleeson DC, Al-Joudeh A, McAlindon ME, Hopper AD, Kumar S , Sidhu R et al (2024) What is the role of out of programme clinical fellowships in the era of Shape of Training? A single-centre cohort study. BMJ Open Gastroenterology, 11(1), e001311-e001311.
Dhali A, Trott N, Shiha MG, Aziz I, Shaw CC, Buckle RL & Sanders DS (2024) Dietetic management of irritable bowel syndrome: A national survey of dietary approaches and decision-making factors. Clinical Medicine, 24, 100132-100132.
Ball AJ, Aziz I, Sargur RB, Merriman L & Kurien M (2024) Rejection of fecal immunochemical tests within the lower gastrointestinal diagnostic pathway: a cohort study. Journal of Primary Care & Community Health, 15. View this article in WRRO
Shiha MG & Aziz I (2023) Amitriptyline for the management of IBS in primary care. Gastroenterology.
Cotton C, Raju SA, Ahmed H, Webster G, Hallam R, Croall I, Coleman S, Trott N, Rej A, Shiha MG , Aziz I et al (2023) Does a gluten-free diet improve quality of life and sleep in patients with non-coeliac gluten/wheat sensitivity?. Nutrients, 15(15).
Jaafari H, Houghton LA, West RM, Agrawal A, Aziz I, Black CJ, Corsetti M, Shuweihdi F, Eugenicos M, Paine PA , Ford AC et al (2023) The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: results from the Rome foundation global epidemiology study. Neurogastroenterology & Motility.
Lorraine-Francis H, Newberry E & Aziz I (2022) Diagnostic yield of upper gastrointestinal endoscopy in patients attending a UK centre with symptoms compatible with Rome IV functional dyspepsia. Frontline Gastroenterology.
Rej A, Avery A, Aziz I, Black CJ, Bowyer RK, Buckle RL, Seamark L, Shaw CC, Thompson J, Trott N , Williams M et al (2022) Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Medicine, 20(1).
Ball AJ, Aziz I, Parker S, Sargur RB, Aldis J & Kurien M (2022) Fecal immunochemical testing in patients with low-risk symptoms of colorectal cancer: a diagnostic accuracy study. Journal of the National Comprehensive Cancer Network, 20(9), 989-996.e1.
Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S , Winning RC et al (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut.
Simons J, Shajee U, Palsson O, Simren M, Sperber AD, Törnblom H, Whitehead W & Aziz I (2022) Disorders of gut‐brain interaction: highly prevalent and burdensome yet under‐taught within medical education. United European Gastroenterology Journal.
Rej A, Sanders DS & Aziz I (2022) This is a response to the letter to the Editor by Staudacher and Gibson, CGH-D-22-01205:. Clinical Gastroenterology and Hepatology.
Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A & Aziz I (2022) Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome : a randomized trial of traditional dietary advice, the low FODMAP diet and the gluten-free diet. Clinical Gastroenterology and Hepatology. View this article in WRRO
Shiha MG & Aziz I (2021) Review article : Physical and psychological comorbidities associated with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 54(S1), S12-S23.
Iribarren C, Magnusson MK, Vigsnæs LK, Aziz I, Amundsen ID, Šuligoj T, Juge N, Patel P, Sapnara M, Johnsen L , Sørensen N et al (2021) The effects of human milk oligosaccharides on gut microbiota, metabolite profiles and host mucosal response in patients with irritable bowel syndrome. Nutrients, 13(11).
Tornkvist NT, Aziz I, Whitehead WE, Sperber AD, Palsson OS, Hreinsson JP, Simrén M & Törnblom H (2021) Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population. United European Gastroenterology Journal.
Ahmed H, Hallam R, Webster G, Rej A, Croall ID, Coleman SH, Key T, Buckle R, Shaw CC, Goodwin J , Aziz I et al (2021) NCGS like IBS ‘type’ symptoms is a diagnosis of exclusion. Nutrition Journal, 20(1). View this article in WRRO
Parker S, Palsson O, Sanders DS, Simren M, Sperber AD, Törnblom H, Urwin H, Whitehead W & Aziz I (2021) Functional gastrointestinal disorders and associated health impairment in individuals with celiac disease. Clinical Gastroenterology and Hepatology.
Rej A, Shaw CC, Buckle RL, Trott N, Agrawal A, Mosey K, Sanders K, Allen R, Martin S, Newton A , Robinson K et al (2021) The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up.. Dig Liver Dis.
Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, Fang X, Fukudo S, Ghoshal UC, Kellow J , Khatun R et al (2021) GREATER OVERLAP OF ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS LEADS TO INCREASED DISEASE SEVERITY AND POORER QUALITY OF LIFE.. Clin Gastroenterol Hepatol.
Aziz I & Simrén M (2020) The overlap between irritable bowel syndrome and organic gastrointestinal diseases. The Lancet Gastroenterology & Hepatology.
Rej A, Aziz I & Sanders DS (2020) Personalising dietary therapies for irritable bowel syndrome – what is gluten’s role. Clinical Gastroenterology and Hepatology.
Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, David Tai FW, Afify S & Aziz I (2020) Diagnostic yield of colonoscopy in patients with symptoms compatible with Rome IV functional bowel disorders. Clinical Gastroenterology and Hepatology.
Tai FWD, Palsson OS, Lam CY, Whitehead WE, Sperber AD, Tornblom H, Simren M & Aziz I (2020) Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.. Neurogastroenterology and Motility.
Shiha MG, Ashgar Z, Fraser EM, Kurien M & Aziz I (2020) High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria. EClinicalMedicine. View this article in WRRO
Schiepatti A, Sanders DS, Aziz I, De Silvestri A, Goodwin J, Key T, Quaye L, Giuffrida P, Vanoli A, Paulli M , Cross SS et al (2020) Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study. European Journal of Gastroenterology & Hepatology. View this article in WRRO
McCulloch SM, Aziz I, Polster AV, Pischel A-B, Stålsmeden H, Shafazand M, Block M, Byröd G, Lindkvist B, Törnblom H , Jonefjäll B et al (2020) The diagnostic value of a change in bowel habit for colorectal cancer within different age groups. United European Gastroenterology Journal, 8(2), 211-219.
Lam CY, Palsson OS, Whitehead WE, Sperber AD, Tornblom H, Simren M & Aziz I (2020) Rome IV functional gastrointestinal disorders and health impairment in subjects with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome. Clinical Gastroenterology and Hepatology. View this article in WRRO
Sundin J, Aziz I, Nordlander S, Polster A, Hu YOO, Hugerth LW, Pennhag AAL, Engstrand L, Törnblom H, Simrén M & Öhman L (2020) Evidence of altered mucosa-associated and fecal microbiota composition in patients with irritable bowel syndrome. Scientific Reports, 10(1). View this article in WRRO
Zammit SC, Schiepatti A, Aziz I, Kurien M, Sanders DS & Sidhu R (2020) The use of small-bowel capsule endoscopy in cases of equivocal celiac disease. Gastrointestinal Endoscopy. View this article in WRRO
Shaw CC, Buckle RL, Rej A, Trott N, Aziz I & Sanders DS (2020) A gluten reduction is the patients’ choice for a dietary ‘bottom up’ approach in IBS—a comment on “a 5Ad dietary protocol for functional bowel disorders” nutrients 2019, 11, 1938. Nutrients, 12(1). View this article in WRRO
Aziz I, Whitehead WE, Palsson OS, Törnblom H & Simrén M (2020) An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Review of Gastroenterology & Hepatology, 14(1), 39-46. View this article in WRRO
Rej A, Buckle RL, Shaw CC, Trott N, Aziz I & Surendran Sanders D (2020) Letter: the gluten-free diet as a bottom-up approach for irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 51(1), 184-185.
Rej A, Aziz I, Tornblom H, Sanders DS & Simrén M (2019) The role of diet in irritable bowel syndrome: implications for dietary advice. Journal of Internal Medicine, 286(5), 490-502.
Rej A, Trott N, Aziz I & Sanders DS (2019) A Gluten-Free Diet. The American Journal of Gastroenterology, 114(9), 1553-1553.
Trott N, Aziz I, Rej A & Surendran Sanders D (2019) How patients with IBS use low FODMAP dietary information provided by general practitioners and gastroenterologists : a qualitative study. Nutrients, 11(6). View this article in WRRO
Croall I, Trott N, Rej A, Aziz I, O'Brien D, George H, Hossain M, Marks L, Richardson J, Rigby R , Hadjivassiliou M et al (2019) A population survey of dietary attitudes towards gluten. Nutrients, 11(6). View this article in WRRO
Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M & Törnblom H (2019) Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults. Clinical Gastroenterology and Hepatology, 17(5), 878-886.
Rej A, Trott N, Sanders DS & Aziz I (2019) Letter: the low FODMAP diet is not the only diet for IBS. Alimentary Pharmacology & Therapeutics, 49(8), 1108-1109.
Rej A, Aziz I & Sanders DS (2019) Breaking bread!. Proceedings of the Nutrition Society, 78(1), 118-125.
Aziz I (2018) The global phenomenon of self-reported wheat sensitivity. American Journal of Gastroenterology, 113(7), 945-948. View this article in WRRO
Aziz I, Törnblom H, Palsson OS, Whitehead WE & Simrén M (2018) How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. The American Journal of Gastroenterology, 113(7), 1017-1025.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE & Simrén M (2018) Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. The Lancet Gastroenterology & Hepatology, 3(4), 252-262.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE & Simrén M (2018) The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. The American Journal of Gastroenterology, 113(1), 86-96.
Aziz I, Peerally MF, Barnes JH, Kandasamy V, Whiteley JC, Partridge D, Vergani P, Cross SS, Green PH & Sanders DS (2017) The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut, 66, 1563-1572. View this article in WRRO
Aziz I, Törnblom H & Simrén M (2017) Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome. Current Opinion in Gastroenterology, 33(3), 196-202. View this article in WRRO
Penny HA, Aziz I, Ferrar M, Atkinson J, Hoggard N, Hadjivassiliou M, West JN & Sanders DS (2016) Is there a relationship between gluten sensitivity and postural tachycardia syndrome?. European Journal of Gastroenterology & Hepatology, 28(12), 1383-1387.
Raju SA, Mooney PD, Aziz I, Kurien M & Sanders DS (2016) Letter: gluten challenge in the era of noncoeliac gluten sensitivity - a change in clinical practice?. Alimentary Pharmacology & Therapeutics, 43(5), 656-656.
Aziz I, Dwivedi K & Sanders DS (2016) From coeliac disease to noncoeliac gluten sensitivity; should everyone be gluten free?. Current Opinion in Gastroenterology, 32(2), 120-127.
Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M & Sanders DS (2015) Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clinical Gastroenterology and Hepatology, 14(5), 696-703.e1.
Aziz I, Mumtaz S, Bholah H, Chowdhury FU, Sanders DS & Ford AC (2015) High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria. Clinical Gastroenterology and Hepatology, 13(9), 1650-1655.e2.
Branchi F, Aziz I, Conte D & Sanders DS (2015) Noncoeliac gluten sensitivity. Current Opinion in Clinical Nutrition and Metabolic Care, 18(5), 508-514.
Aziz I, Hadjivassiliou M & Sanders DS (2015) The spectrum of noncoeliac gluten sensitivity. Nature Reviews Gastroenterology & Hepatology, 12(9), 516-526.
Aziz I, Branchi F, Pearson K, Priest J & Sanders DS (2015) A Study Evaluating the Bidirectional Relationship Between Inflammatory Bowel Disease and Self-reported Non-celiac Gluten Sensitivity. Inflammatory Bowel Diseases, 21(4), 847-853.
Aziz I, Branchi F & Sanders DS (2015) The rise and fall of gluten!. Proceedings of the Nutrition Society, 74(3), 221-226.
Aziz I, Kurien M, Sanders DS & Ford AC (2015) Screening for bile acid diarrhoea in suspected irritable bowel syndrome. Gut, 64(5), 851.1-851.
Aziz I, Hadjivassiliou M & Sanders DS (2014) Self-Reported Gluten Sensitivity: An International Concept in Need of Consensus?. American Journal of Gastroenterology, 109(9), 1498-1499.
Aziz I, Karajeh MA, Zilkha J, Tubman E, Fowles C & Sanders DS (2014) Change in awareness of gluten-related disorders among chefs and the general public in the UK. European Journal of Gastroenterology & Hepatology, 26(11), 1228-1233.
Lin S, Mooney PD, Kurien M, Aziz I, Leeds JS & Sanders DS (2014) Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. European Journal of Gastroenterology & Hepatology, 26(10), 1176-1180.
Aziz I, Key T, Goodwin JG & Sanders DS (2014) Predictors for Celiac Disease in Adult Cases of Duodenal Intraepithelial Lymphocytosis. Journal of Clinical Gastroenterology, 1-1.
Aziz I, Hadjivassiliou M & Sanders DS (2014) Editorial: noncoeliac gluten sensitivity - a disease of the mind or gut?. Alimentary Pharmacology & Therapeutics, 40(1), 113-114.
Aziz I & Hadjivassiliou M (2014) Noncoeliac gluten sensitivity—food for thought. Nature Reviews Gastroenterology & Hepatology, 11(7), 398-399.
Aziz I & Sanders DS (2014) Patients Who Avoid Wheat and Gluten: Is That Health or Lifestyle?. Digestive Diseases and Sciences, 59(6), 1080-1082.
Aziz I, Lewis NR, Hadjivassiliou M, Winfield SN, Rugg N, Kelsall A, Newrick L & Sanders DS (2014) A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. European Journal of Gastroenterology & Hepatology, 26(1), 33-39.
Mooney PD, Aziz I & Sanders DS (2013) Non-celiac gluten sensitivity: clinical relevance and recommendations for future research. Neurogastroenterology & Motility, 25(11), 864-871.
Swallow K, Wild G, Sargur R, Sanders DS, Aziz I, Hopper AD & Egner W (2013) Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time. Clinical & Experimental Immunology, 171(1), 100-106.
Kurien M, Evans KE, Aziz I, Sidhu R, Drew K, Rogers TL, McAlindon ME & Sanders DS (2013) Capsule endoscopy in adult celiac disease: a potential role in equivocal cases of celiac disease?. Gastrointestinal Endoscopy, 77(2), 227-232.
Sanders DS & Aziz I (2012) Editorial: Non-Celiac Wheat Sensitivity: Separating the Wheat from the Chat!. American Journal of Gastroenterology, 107(12), 1908-1912.
Aziz I & Sanders DS (2012) The Irritable Bowel Syndrome-Celiac Disease Connection. Gastrointestinal Endoscopy Clinics of North America, 22(4), 623-637.
Aziz I & Sanders DS (2012) Emerging concepts: from coeliac disease to non-coeliac gluten sensitivity. Proceedings of the Nutrition Society, 71(4), 576-580.
Aziz I & Sanders DS (2012) Are we diagnosing too many people with coeliac disease?. Proceedings of the Nutrition Society, 71(4), 538-544.
Aziz I, Hadjivassiliou M & Sanders DS (2012) Does gluten sensitivity in the absence of coeliac disease exist?. BMJ, 345(nov30 1), e7907-e7907.
Evans KE, Aziz I, Cross SS, Sahota GRK, Hopper AD, Hadjivassiliou M & Sanders DS (2011) A Prospective Study of Duodenal Bulb Biopsy in Newly Diagnosed and Established Adult Celiac Disease. American Journal of Gastroenterology, 106(10), 1837-1742.
Aziz I, Evans KE, Papageorgiou V & Sanders DS (2011) Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?. J Gastrointestin Liver Dis, 20(1), 27-31.
Aziz I, Evans KE, Hopper AD, Smillie DM & Sanders DS (2010) A prospective study into the aetiology of lymphocytic duodenosis. Alimentary Pharmacology & Therapeutics, 32(11-12), 1392-1397.
Choudhary A, Fikree A, Ruffle JK, Takahashi K, Palsson OS, Aziz I & Aziz Q () A machine learning approach to stratify patients with hypermobile Ehlers‐Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life. Neurogastroenterology & Motility.
Dhali A, Trott N, Shiha MG, Aziz I, Shaw CC, Buckle RL & Sanders DS () Dietetic Management of Irritable Bowel Syndrome: A National Survey of Dietary Approaches and Decision-making Factors. Journal of Gastrointestinal and Liver Diseases, 33(2), 177-183.
Brown LC & Aziz I () Prevalence and Burden of Disorders of Gut-Brain Interaction Among UK Medical Students. International Journal of Medical Students, 12(1), 43-52.
Penny HA, Aziz I & Lam C () Mast cell activation and nutritional disorders in patients with hypermobility. Current Opinion in Gastroenterology.
Buckle RL, Brown LC & Aziz I () Randomized trial in postprandial functional dyspepsia: Reassurance and diagnostic explanation with or without traditional dietary advice. Neurogastroenterology & Motility.
Rej A, Sanders DS & Aziz I () Further research needed to determine first-line therapy for IBS in primary care. Gut.
Schiepatti A, Rej A, Maimaris S, Cross SS, Porta P, Aziz I, Key T, Goodwin J, Therrien A, Yoosuf S , Leffler DA et al () Clinical classification and long‐term outcomes of seronegative coeliac disease: a 20‐year multicentre follow‐up study. Alimentary Pharmacology & Therapeutics.
Archer T, Aziz I, Kurien M, Knott V & Ball A () Prioritisation of lower gastrointestinal endoscopy during the COVID-19 pandemic: outcomes of a novel triage pathway. Frontline Gastroenterology.
Rej A, Sanders DS, Buckle RL, Trott N, Aziz I & Shaw CC () What is the optimal FODMAP threshold in IBS?. Journal of Gastroenterology and Hepatology.
Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S & Aziz I () Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterology & Motility.
Rej A, Aziz I & Sanders DS () Coeliac disease and noncoeliac wheat or gluten sensitivity. Journal of Internal Medicine.
Rej A, Buckle RL, Shaw CC, Trott N, Urwin H, McGough N, Aziz I & Sanders DS () National survey evaluating the provision of gastroenterology dietetic services in England. Frontline Gastroenterology.
Rej A, Buckle RL, Shaw CC, Trott N, Aziz I & Sanders DS () Is CBT the dominant non-drug IBS treatment? The rise of dietary therapies. Gut.
Croall ID, Hoggard N, Aziz I, Hadjivassiliou M & Sanders DS () Brain fog and non-coeliac gluten sensitivity: Proof of concept brain MRI pilot study. PLOS ONE, 15(8), e0238283-e0238283.
Iribarren C, Törnblom H, Aziz I, Magnusson MK, Sundin J, Vigsnæs LK, Amundsen ID, McConnell B, Seitzberg D, Öhman L & Simrén M () Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double‐blind, placebo‐controlled study. Neurogastroenterology & Motility.
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP , Moss-Morris R et al () British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut.

Chapters

Aziz I & Simrén M (2020) Small Intestinal Bacterial Overgrowth, Encyclopedia of Gastroenterology (pp. 454-458). Elsevier
Aziz I & Simrén M (2020) Irritable Bowel Syndrome, Encyclopedia of Gastroenterology (pp. 312-323). Elsevier
Aziz I & Sanders DS (2014) Coeliac disease and nutrition, ADVANCED NUTRITION AND DIETETICS IN GASTROENTEROLOGY (pp. 160-168).

Teaching interests: My teaching and other lecture duties cover clinical gastroenterology on both the MBChB and BDS course. I also provide postgraduate teaching to both junior doctors and allied healthcare professionals.

School of Medicine and Population Health

School of Medicine and Population Health

Dr Imran Aziz

Featured publications

Journal articles

Chapters

All publications

Journal articles

Chapters

Links